These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 25985250)

  • 1. Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine.
    Viennois E; Zhao Y; Merlin D
    Inflamm Bowel Dis; 2015 Oct; 21(10):2467-74. PubMed ID: 25985250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New proteomic approaches for biomarker discovery in inflammatory bowel disease.
    Roda G; Caponi A; Benevento M; Nanni P; Mezzanotte L; Belluzzi A; Mayer L; Roda A
    Inflamm Bowel Dis; 2010 Jul; 16(7):1239-46. PubMed ID: 20127998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine in the treatment of inflammatory bowel diseases.
    Parfenov AI; Knyazev OV; Kagramanova AV; Fadeeva NA
    Ter Arkh; 2018 Feb; 90(2):4-11. PubMed ID: 30701765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease-personalised medicine in its infancy.
    Stevens TW; Matheeuwsen M; Lönnkvist MH; Parker CE; Wildenberg ME; Gecse KB; D'Haens GR
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1213-1231. PubMed ID: 30378142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine.
    Giachero F; Jenke A; Zilbauer M
    Expert Rev Clin Immunol; 2021 Aug; 17(8):871-881. PubMed ID: 34142929
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers in inflammatory bowel disease: current practices and recent advances.
    Iskandar HN; Ciorba MA
    Transl Res; 2012 Apr; 159(4):313-25. PubMed ID: 22424434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex.
    Brooks J; Watson A; Korcsmaros T
    Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):101-109. PubMed ID: 28373027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Biomarkers in IBD.
    Rogler G; Biedermann L
    Curr Gastroenterol Rep; 2015 Jul; 17(7):26. PubMed ID: 26122247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in IBD Research: Precision Medicine.
    Denson LA; Curran M; McGovern DPB; Koltun WA; Duerr RH; Kim SC; Sartor RB; Sylvester FA; Abraham C; de Zoeten EF; Siegel CA; Burns RM; Dobes AM; Shtraizent N; Honig G; Heller CA; Hurtado-Lorenzo A; Cho JH
    Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S31-S39. PubMed ID: 31095701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
    Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on diagnostic and prognostic biomarkers in inflammatory bowel disease.
    Day AS; Leach ST; Lemberg DA
    Expert Rev Mol Diagn; 2017 Sep; 17(9):835-843. PubMed ID: 28770636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel Disease.
    Torres J; Halfvarson J; Rodríguez-Lago I; Hedin CRH; Jess T; Dubinsky M; Croitoru K; Colombel JF
    J Crohns Colitis; 2021 Sep; 15(9):1443-1454. PubMed ID: 33730755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
    Barnes EL; Burakoff R
    Inflamm Bowel Dis; 2016 Dec; 22(12):2956-2965. PubMed ID: 27763951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
    Iborra M; Beltrán B; Nos P
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):641-56. PubMed ID: 27633593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.
    Jiang W; Li X
    Mol Diagn Ther; 2015 Jun; 19(3):141-58. PubMed ID: 25990388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biomarkers in the diagnosis and therapy of inflammatory bowel diseases].
    Iijima H; Shinzaki S; Tsujii M; Takehara T
    Nihon Rinsho; 2012 May; 70(5):869-73. PubMed ID: 22620015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the Path Forward for Biomarkers to Address Unmet Needs in Inflammatory Bowel Diseases.
    Honig G; Heller C; Hurtado-Lorenzo A
    Inflamm Bowel Dis; 2020 Sep; 26(10):1451-1462. PubMed ID: 32812036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Future of Biomarkers.
    Vincent JL; Bogossian E; Menozzi M
    Crit Care Clin; 2020 Jan; 36(1):177-187. PubMed ID: 31733679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL; Abreu MT
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD).
    Verstockt S; Verstockt B; Vermeire S
    Expert Opin Ther Targets; 2019 Nov; 23(11):943-954. PubMed ID: 31587593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.